Last year, U.S. venture capital investment dropped to its lowest level in over a decade, according to data from the PricewaterhouseCoopers Moneytree Survey and the National Venture Capital Association (NVCA). This drop was fueled by the national economic crisis, which created a number of issues within the industry.
Between 2003 and 2007 R&D spending at U.S. small businesses increased by 38.8 percent, according to a recent National Science Foundation InfoBrief. During that period the share of U.S. R&D done by firms with fewer than 500 employees increased from 17.9 percent to 18.7 percent. R&D intensity at small firms also increased from 3.1 percent of company sales revenues to 8.6 percent. Read the NSF InfoBrief "Indicators of U.S.
For the first time in more than a decade, U.S. patent activity did not increase in 2008 over the previous year, according to IEEE Spectrum's Patent Power rankings. The annual report, which ranks companies, universities and research institutions by the quality of their U.S. patent portfolio, also finds that the number of U.S.-based organizations that placed within the top tier of IEEE's rankings-by-industry had fallen by 30 percent.
Finance reform legislation, bound for the Senate floor in April, could have significant repercussions for investors and entrepreneurs. The bill, introduced by Senator Christopher Dodd (D-CT), would create a new consumer protection watchdog within the Federal Reserve, install new regulations and safety valves to prevent another financial meltdown, and provide greater transparency within the financial industry. Two short provisions, however, have caught the attention of the private equity community and could change the rules for investors.
The Office of Science and Technology Policy and the National Economic Council have issued a request for information (RFI) on how best to encourage the commercialization of university research and on whether proof of concept centers are an effective tool in early-stage commercialization. The RFI asks for models, strategies and metrics that can help universities contribute to economic development. Responses are due by April 26.
Witnessing the success experienced by its neighbor, West Virginia is creating a university R&D matching endowment program similar to Kentucky’s. The legislature approved $50 million for Gov. Joe Manchin’s “Bucks for Brains” initiative to be allocated from lottery surplus funds (see the Jan. 16, 2008 issue of the Digest).
Adjourning from the 2008 legislative session on March 13, Virginia legislators passed the fiscal year 2008-10 biennial budget but immediately called for a special session to resolve differences in the proposed capital outlay plan that supports university R&D and commercialization efforts.
Three of the major thrusts for the research investments of many states – hydrogen energy technologies, nanomanufacturing, and intelligent and integrated manufacturing – are the focus of a new report by a federal Interagency Working Group on Manufacturing R&D. Manufacturing the Future: Federal Priorities for Manufacturing R&D describes the significance of each of the three critical manufacturing R&D areas, details the challenges essential for progress, discusses existing interagency collaborations and provides recommendations for future research.
SSTI Gives Readers Closer Look at the Data
Last year, Congress authorized $5.9 billion in new spending on research, education and entrepreneurship as part of the Bush Administration’s decade-long $50 billion American Competitiveness Initiative (ACI). Though Congress did not appropriate a significant amount of new funding to match this authorization, many remain committed to the goals of the ACI.
SSTI’s VC Dashboard Value Enlarged with Addition of Per Capita Data
Two weeks ago, Idaho Gov. C.L. “Butch” Otter vetoed legislation to repeal state R&D income tax credits for Idaho companies. Among his reasons for the veto, Gov. Otter claimed removing the credits would put Idaho at a competitive disadvantage because surrounding states over similar incentives. Was he right?
As Massachusetts legislators are in the process of crafting a compromise bill for the statewide Life Sciences Initiative, one new issue to emerge would have the state taking an equity position in the life sciences companies in which the state provides financial support.
In its first state R&D survey since 1998, the National Science Foundation (NSF) finds 252 different state agencies across the country directly supported R&D and R&D facilities totaling $1.1 billion in fiscal year 2006. The survey, released this morning, was conducted for NSF by the U.S. Census Bureau.
“I recognize the importance of attracting venture capital and new investments to Maine,” Gov. John E. Baldacci said. The governor later added, “However, as it is currently written the bill carries enormous risk. This bill would guarantee a rate of return for venture capital investors while Maine would shoulder all the risk. The potential liability for the State is too great for me to sign this bill.”
The General Assembly approved the fiscal year 2009 budget last week, providing $21 million for the Life Sciences Research Trust Fund. Established in 2003, the fund was created to support life science research, commercialization, and technology transfer using a portion of the state’s tobacco settlement funds. The FY09 appropriation will be administered by the Life Sciences Research Board, which is responsible for awarding grants and contracts for research.
During the 1990s, especially the mid- to late-part of the decade, many countries experienced booms in their high-tech and venture capital industries. Few, however, grew at the same pace as Israel.
Israeli entrepreneurs created eight times as many high-tech companies during the 1990s than in the previous decade and equity investment in Israeli start-ups grew from $50 million to $6.65 billion. The number of venture capital companies in the country jumped from two in 1990 to about 100 in 2000.
Throughout most of the history of the U.S. venture capital industry, expanding, and not start-up companies, have been the primary focus of venture investors. Recent data from the PricewaterhouseCoopers and National Venture Capital Association (NVCA) annual MoneyTreeTM Report indicates that investors are beginning to focus on even later-stage companies, which could be a problem for entrepreneurs and states trying to attract earlier-stage dollars.
To encourage innovation in research, the Howard Hughes Medical Institute (HHMI) recently awarded $600 million to 56 biomedical scientists who will investigate and pursue scientific discoveries ranging from microbiology and immunology to bioengineering and synthetic biology.
On June 5, 2008, the government of the Grand Duchy of Luxembourg announced plans for a $200 million five-year molecular medicine initiative that draws on a strategic partnership involving three Luxembourg Public Research Centers (CRPs), the University of Luxembourg and three U.S. research institutes prominent in the field.
The U.S. research institutions include:
A little more than a year after unveiling a comprehensive proposal to provide crucial funding for R&D, commercialization and infrastructure to position Massachusetts as a global leader in life sciences, Gov. Deval Patrick signed an historic 10-year, $1 billion life sciences investment package, transforming the ambitious idea into reality.
Last week, Premier Ed Stelmach of Alberta introduced a $170 million suite of initiatives to support high-tech economic development in the province. The government hopes that by providing support for commercialization from research to market it can attract high-tech entrepreneurs from other areas. Most of the province's investment will support the creation of the $100 million Alberta Enterprise Corporation to encourage venture capital investment.
An initiative in Iowa to disperse tax credits worth 20 percent of equity investments into pre-qualified businesses or seed capital funds has reached its $10 million cap and will not be continued in the next fiscal year. The Iowa Venture Capital Credit – Qualified Business or Seed Capital Fund was started in 2002 with a cap of $10 million, and as monitored by the Iowa Department of Revenue, all credits have been issued.
As annual appropriations for the National Institutes of Health (NIH) flattened – at the same time more and more states and universities are increasing their investments in academic bioscience research capacity – competition for NIH grants has heightened. Reports indicate investigators in the early stages of their careers and transformative research have been the victims of the squeeze.
New York City officials recently announced the launch of a $2 million seed fund to boost entrepreneurship and the local venture capital market. NYC Seed will provide up to $200,000 for seed-stage New York-based businesses and will offer mentoring and other support for client companies.